FDA Panel Recommends Approval of the First Gene Therapy Treatment

This article originally appeared on Time.com.An advisory panel for the FDA recommended approving the first gene therapy for use in the U.S., and the treatment is meant for children with B-cell acute lymphoblastic leukemia, the most common blood cancer in children. The FDA doesn’t have to follow the advice of the advisory committee, but it often does.The new therapy, called chimeric antigen receptor T cell (CAR-T) therapy, provides new hope that the disease won’t just be treated, but